Nowadays, early ADA restoration, by either enzyme replacement therapy, allogeneic hematopoietic stem cell transplantation (HSCT), or gene therapy, is available and prevents patients from severe immunodeficiency [3]. This evidence concerns the gene ADA and immunodeficiency disease.